Viracta Therapeutics Ownership | Who Owns Viracta Therapeutics?
Viracta Therapeutics Ownership Summary
Viracta Therapeutics is owned by 14.12% institutional investors, 2.84% insiders, and 83.04% retail investors. Vanguard group is the largest institutional shareholder, holding 2.95% of VIRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.30% of its assets in Viracta Therapeutics shares.
VIRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Viracta Therapeutics | 14.12% | 2.84% | 83.04% |
| Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
| Industry | Biotech Stocks | 47.04% | 8.74% | 44.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 1.16M | 2.95% | $631.39K |
| Samsara biocapital | 689.71K | 1.75% | $375.00K |
| Laurion capital management lp | 407.30K | 1.04% | $221.45K |
| Aisling capital management lp | 288.57K | 0.73% | $156.90K |
| Blackrock | 273.30K | 0.69% | $148.59K |
| Geode capital management | 270.77K | 0.69% | $147.26K |
| Renaissance | 217.70K | 0.55% | $118.36K |
| Morgan stanley | 134.54K | 0.34% | $73.15K |
| Bridgeway capital management | 74.00K | 0.19% | $40.23K |
| State street | 65.87K | 0.17% | $35.81K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Samsara biocapital | 689.71K | 0.08% | $375.00K |
| Aisling capital management lp | 288.57K | 0.07% | $156.90K |
| Planning capital management | 7.27K | 0.00% | $3.95K |
| Laurion capital management lp | 407.30K | 0.00% | $221.45K |
| Wealthtrust axiom | 11.40K | 0.00% | $6.20K |
| Inspirion wealth advisors | 15.00K | 0.00% | $8.16K |
| Virtu financial | 30.79K | 0.00% | $17.00K |
| Rp management | 3.70K | 0.00% | $2.00K |
| Trust co of toledo na /oh/ | 12.32K | 0.00% | $6.70K |
| Xtx topco | 19.20K | 0.00% | $10.44K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Virtu financial | 30.79K | 0.00% | 30.79K |
| Geode capital management | 270.77K | - | 18.07K |
| Morgan stanley | 134.54K | - | 16.53K |
| Renaissance | 217.70K | 0.00% | 15.20K |
| Tower research capital llc (trc) | 12.65K | 0.00% | 3.76K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bvf inc/il | - | - | -3.61M |
| Ensign peak advisors | - | - | -61.60K |
| Blackrock | 273.30K | - | -30.68K |
| Mai capital management | - | - | -27.42K |
| United bank | - | - | -25.20K |
Sold Out
| Holder | Change |
|---|---|
| Qube research | -2.00 |
| Newedge advisors | -14.00 |
| Nbc securities | -1.40K |
| Royal bank of canada | -2.07K |
| Beacon pointe advisors | -15.00K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | 37 | -9.76% | 5,587,200 | -38.10% | 14 | 2.68% | 16 | 60.00% | 6 | -25.00% |
| Jun 30, 2024 | 41 | - | 9,025,612 | -3.92% | 22 | 3.88% | 10 | -23.08% | 8 | 33.33% |
| Mar 31, 2024 | 41 | -6.82% | 9,393,496 | -3.67% | 24 | 3.83% | 13 | -13.33% | 6 | -14.29% |
| Dec 31, 2023 | 44 | 2.33% | 9,751,265 | 0.61% | 25 | 3.99% | 15 | -6.25% | 7 | -12.50% |
| Sep 30, 2023 | 43 | 2.38% | 9,692,391 | -2.75% | 25 | 3.74% | 16 | 45.45% | 8 | -20.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 513.47K | 1.30% | -131.32K |
| Vanguard Institutional Extnd Mkt Idx Tr | 282.49K | 0.71% | - |
| Fidelity Extended Market Index | 145.27K | 0.37% | -9.48K |
| Bridgeway Ultra-Small Company Market | 74.00K | 0.19% | - |
| BlackRock Extended Equity Market K | 49.16K | 0.12% | -21.00 |
| Fidelity Total Market Index | 41.22K | 0.10% | - |
| Fidelity Series Total Market Index | 28.47K | 0.07% | - |
| Vanguard Instl Ttl Stck Mkt Idx Tr | 28.45K | 0.07% | - |
| Fidelity Nasdaq Composite Index | 25.76K | 0.07% | - |
| NT Ext Equity Mkt Idx Fd - NL | 18.41K | 0.05% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 27, 2024 | Chevallard Daniel R. | CFO and COO | Sell | $2.49K |
| Nov 30, 2023 | Rothera Mark | President and CEO | Buy | $25.73K |
| Dec 01, 2023 | Rothera Mark | President and CEO | Buy | $23.63K |
| Nov 28, 2023 | Chevallard Daniel R. | CFO and COO | Sell | $1.86K |
| Aug 28, 2023 | Chevallard Daniel R. | CFO and COO | Sell | $5.09K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | 1 |
| 2023 Q4 | 2 | 1 |
VIRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools